Numentus Technologies Inc.
Menlo Park, CA
- UEI
- HGYJGDEE8CM6
- CAGE
- 8UEJ5
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- SRI International, 333 Ravenswood Ave, Menlo Park, CA 94025, USA
- Website
- numentus.net
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Hemex Health Inc. | Portland, OR | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
| Captis Diagnostics Inc. | Pittsburgh, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Dotquant LLC | Shoreline, WA | — |
| Endomimetics, Inc. | Birmingham, AL | — |
| Neurodex Inc. | Natick, MA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Numentus Technologies Inc. is a for-profit corporate entity registered in SAM.gov since December 2020, specializing in advanced biomedical and diagnostic technology development. The company focuses on creating innovative scientific instrumentation and analytical platforms, with a primary emphasis on high-speed imaging, molecular diagnostics, and extracellular vesicle (EV) analysis technologies. Their research and development efforts seem centered on developing cutting-edge diagnostic and research tools that can provide rapid, high-throughput, and multiplexed analysis across various biological domains.
Through federal grant awards, Numentus Technologies Inc. has consistently secured project grants from multiple civilian federal agencies, primarily focused on developing advanced scientific instrumentation. The National Institutes of Health (NIH) agencies, including the National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Mental Health, and National Institute on Aging, have been significant funders of their work. Their grant-funded projects have encompassed developing high-speed hyperspectral imaging technologies for multiplexed immunofluorescence, creating rapid PCR diagnostic platforms for viral detection (including SARS-CoV-2 and influenza), and advancing single extracellular vesicle analysis technologies for potential applications in Alzheimer's disease, cancer diagnostics, and bacterial characterization. The company's research consistently aims to create innovative technological platforms that can provide more detailed, faster, and more cost-effective analysis across medical research and diagnostic domains, with particular emphasis on improving detection methods for complex biological samples.
Quick answers
Is Numentus Technologies Inc. registered in SAM.gov?
Yes. Numentus Technologies Inc.'s SAM.gov registration is active through August 18, 2027.
What is Numentus Technologies Inc.'s most recent federal award?
Numentus Technologies Inc.'s most recent federal grant award is High-throughput high-content nanoscale extracellular vesicle analysis (R43GM156162), from National Institute of General Medical Sciences (NIH), on July 5, 2024.
On GovTribe
See Numentus Technologies Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors